3-hydroxy-4,4-dimethyl-1-(thiophen-3-yl)pent-2-en-1-one, 98%, 250mg

9-Isopropyl-N-(3-(trifluoromethyl)benzyl)-9H-purin-6-amine, 99.00%, 10mg

(9,9-Diphenyl-9H-fluoren-2-yl)boronic acid, 97.0%, 1g

1,2-bis(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethane tetrahydrochloride, 95%, 250mg

N-(6-Bromohexyl)phthalimide>98.0%(GC)25g

tert-Butyl (2S,4R)-4-amino-2-methylpiperidine-1-carboxylate, 98%, 500mg

3-Bromo-5-isopropoxyaniline, 98%, 250mg

2-(chloromethyl)-8-fluoro-4(1H)-quinolinone, 95.0%, 5g

5-Bromo-N4-ethylpyridine-3,4-diamine, 95.0%, 1g

TERT-BUTYL 8-HYDROXY-5-AZASPIRO[2.5]OCTANE-5-CARBOXYLATE, 95.0%, 250mg

Thiazolo[5,4-c]pyridine, 95.0%, 100mg

3-chloro-4-(3,5-dimethyl-1-piperidinyl)aniline, 95.0%, 5g

Solución de hematoxilina A según. hacia Weigert